Latest results and future steps were discussed at the annual meeting
During the annual meeting on 21st – 22nd April 2016 in Geneva presentations on latest results illustrated the progress made in 2015. Two peer-reviewed papers about the progress made are prepared at the moment. The planning of both clinical trials, IPE in Geneva, RPE in Vienna, further evolved. After the finalization of procedures in Geneva, a Scientific Advice meeting in Vienna is currently planned. The TargetAMD consortium is planning to be present at the ESGCT conference this year in Florence.
2. May 2016
Categories: Target AMD